home / stock / vcnx / vcnx news


VCNX News and Press, Vaccinex Inc. From 03/31/20

Stock Information

Company Name: Vaccinex Inc.
Stock Symbol: VCNX
Market: NASDAQ
Website: vaccinex.com

Menu

VCNX VCNX Quote VCNX Short VCNX News VCNX Articles VCNX Message Board
Get VCNX Alerts

News, Short Squeeze, Breakout and More Instantly...

VCNX - Vaccinex Announces up to $16.5 Million in Equity Financing Agreements and Provides an Update on COVID-19 Impact on its Clinical Programs

ROCHESTER, N.Y., March 31, 2020 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and neurodegenerative diseases, today announced that the company has entered into two agreements that combi...

VCNX - Vaccinex EPS beats by $0.18, misses on revenue

Vaccinex (NASDAQ: VCNX ): FY GAAP EPS of -$2.47 beats by $0.18 . Revenue of $0.52M (-27.8% Y/Y) misses by $0.05M . Press Release More news on: Vaccinex, Inc., Earnings news and commentary, Healthcare stocks news, ,

VCNX - Vaccinex Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

On-track to report topline data from CLASSICAL-Lung and SIGNAL clinical trials this year Announces expansion of pepinemab development program into Alzheimer’s disease Completes private placement of common stock, raising gross proceeds of $7.5 million ROCHESTER, N.Y., Mar...

VCNX - DYNT, ALT, GKOS and VIR among midday movers

Gainers: iBio (NYSEMKT: IBIO ) +181% . More news on: iBio, Inc., Dynatronics Corporation, Altimmune, Inc., Stocks on the move, , Read more ...

VCNX - Vaccinex Announces Three Oral Presentations Highlighting Semaphorin 4D (SEMA4D) at the ASCO-SITC Clinical Immuno-Oncology Symposium

ROCHESTER, N.Y., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in cancer and neurodegenerative diseases, today announced that three oral presentations highlighting SEMA4D will be de...

VCNX - Daily Insider Ratings Round Up 1/27/20

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

VCNX - Vaccinex joins coronavirus-stoked rally, up 39%

Ultra-thinly traded micro cap Vaccinex ( VCNX +39% ) jumps on a 29x surge in volume, a modest 152K shares, apparently joining the coronavirus rally. More news on: Vaccinex, Inc., NanoViricides, Inc., Moderna, Inc., Healthcare stocks news, Stocks on the move, Read more ...

VCNX - BLCM, NNVC, EPZM and EHTH among midday movers

Gainers: Allied Healthcare Products (NASDAQ: AHPI ) +115% . More news on: Allied Healthcare Products, Inc., NanoViricides, Inc., Vaccinex, Inc., Stocks on the move, , Read more ...

VCNX - RAD, CAMP, ABEO and MRNS in midday movers

Gainers:  Marinus Pharmaceuticals (NASDAQ: MRNS ) +42% . More news on: Marinus Pharmaceuticals, Inc., Prothena Corporation plc, Applied Genetic Technologies Corporation, Stocks on the move, Read more ...

VCNX - Vaccinex Announces $3 Million Award from the Alzheimer's Drug Discovery Foundation

ROCHESTER, N.Y., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering novel antibody therapies in neurodegenerative diseases and cancer, today announced that it has been granted an award, in the form of an investment of up to app...

Previous 10 Next 10